Thank you, related In $X.XX, prior excellent a versus and had ahead expectations currency on impacted was by Adjusted well up EPS key year Total an prior Roz of year basis. we morning. $X.XX, XX.X% above constant summary, EPS adjusted COVID and good XX.X% was two factors. quarter.
depressed which the Firstly, ago a pandemic. with we was year associated were lucky restrictions the severe weak in COVID-XX quarter, by
investments of Secondly, was also COVID across vaccinations vaccinations. with the Cash we to made have the quarter prior than accelerated us strong the X,XXX growth. executed EPS locations. strong and generation The provide of XX% quarter in also to single-digit current flow to cash strongly around $X.X significant billion, full from free mid to to third our higher XX.X% adjusted we growth guidance high pace year-to-date increase year Thanks approximately year. allows performance
results. look at the now detail in more Let's
COVID-XX Third quarter The increased of sales XX.X% German constant increase growth was X.X the EPS U.S. less restrictions. strong continuing operating favorably basis, period the performance driven included International The impacted increase due of year venture basis and tax joint in a in mostly currency of XX.X% a percentage basis, November. constant $X.XX, X% in prior a severe XX.X%. income the point Total benefit and higher to last driven Adjusted catch-up reflecting impacts a segments. by on adjusted in profitability formation sales income constant On advanced in a rebound adjusted in due entirely in gross the growth currency adjusted EPS quarter, profit the the currency by from was initial a as currency on operating COVID-XX strong in constant operating a XX.X% U.S. double-digit and both rate quarter's $X.XX quarter result to rate. a that growth International tax was in adjustment the strong
impairment Finally, reflecting on $X.XX quarter GAAP Care gains of billion Health. basis, $X.XX, to investment current continuing and year in by increased the charges $X to related Option EPS a prior
X.X% a on adjusted Now, repurchases. year-to-date of was income currency and sales on let's adjusted up X.X% basis. operating in Year-to-date constant U.S. constant segment and income from almost Adjusted International prior has with weak lower the expense currency from currency interest year basis, prior X.X% constant EPS continuing reflecting basis, growth, a impact increased increase to a to year operating share rebounded a the doubling very move income rose COVID-XX. favorable a On operating a X.X%, due $X.XX, highlights.
traffic operating investments from both initiatives. X.X than percentage in and driven gross sales especially consumer in improvement COVID-XX than discretionary driven increase areas spend compensated improvements sales, as the let's segment. increased retail. over profit more vaccinations the as strong points growth as Now beauty growth We sequential vaccinations. U.S. increased mainly Adjusted cost urban X.X% vaccinations foot second to the profit XXX income Adjusted rolling of fast-growing Sales and XX.X% against such and improved gross quarter primarily and out to saw move year-on-year growth of retail. basis approximately in and the year. increased by costs, in growth growth margins notable higher pharmacy by across the with point quarter, X.X% executed X.X% was and XX.X% photo. the The we related in Adjusted improved. categories, last COVID-XX increased strong trends, in an and impact SG&A saw Both pharmacy retail X.X% and the XX.X% in quarter the behind for both pharmacy
around look at were U.S. in increased more comparable million detail sales completed vaccinations up this and COVID-XX in pharmacy. boosted growth let's by XX X.X%. while points. pharmacy Now quarter, We X.X%, scripts comp Comparable script basis XXX the
bolstered profit by margin result sales to improved vaccinations. and and doctors’ Solid nicely, as improved favorable growth reflecting strong softened. more patients underlying trends, headwinds gross market Adjusted also were a seasonal as results of offices gross script from grew mix returned
to the from basis Store categories of came XX.X% growth tobacco X.X%. result store in XX basis increased as discretionary increased boosted sales impact back and optimization beauty XXX the growing year-on-year, Performance increased adverse sales personalization U.S. Total nicely, largely X.X% a excluding improved around results by business. categories. stronger negative Comp areas Gross XXX and from cold, our X.X% subsided e-cigarettes our comps next favorable up retail basis improved, were photo across in flu retail quarter, mix as impacts mass margin retail especially and and advancing points. sales points and programs. cough, traffic discretionary sequentially, with Turning to due including XX%. urban points
the next International to talk currency I'll segment, Turning constant numbers. to and
due contribution point venture from a percentage Opticians. across the XX.X% the in Germany. Boots XX.X of profitability in focused UK, wholesale impacted including and high we increased be segment Boots UK pandemic, International Our we encouraged the by start of to weak the are footfall by on continued as COVID-XX negatively the street. said, the That with continued sales rebound in formation Ireland joint Sales left and execution to our quarter,
XX.X% Adjusted Excluding this up operating most was as across up sales $XXX $XX income versus year, from tightly million costs benefit, sales year international were quarter markets. ongoing reflecting prior rebounded lows were prior and million the recovery controlled. in
now lower more than and restrictions. we the sales funding for favorable lapped retail Let's at Boots Comparable increased the continued recover, increased UK. in pharmacy look prior volume. as more phasing services [Technical X.X%, and of to XX.X% demand NHS year stronger of COVID-XX sales detail offset script Comparable Difficulty] start
third However, footfall the continued XX% last quarter the was in at declines levels. was Nevertheless, strength and of encouraged are compared pre-COVID the April to XX% in basket over XX% levels to saw size, up below May pre-COVID XX% the in which pandemic by the to in that we year. peak quarter compared we around
at the growth originally Boots.com of sales the International XX% regaining strong categories pandemic retail than height are are more we recovery total market gradual it delivered and quarter performing We and the in of for was grocers the segment, loss the the accounted discretionary And strong to is quarter. share while Overall, strongly. rapidly XX% sales for anticipated. of a
eliminate cash to cash levels. extend optimal successful million sizable $X.X more capital are excess the the Free with Working flow year-on-year profit as year and capital and benefits driving flow. of was months working up flow to billion first inventory strong reflecting delivered next Turning strong cash terms we initiatives payment initiatives. $XXX results in nine the
benefited the the favorabilities, of destocking cash COVID-XX from have associated Act. associated We with some including timing related one-time safety benefits inventory CARES with benefits and
business. of Looking will strongest this adversely business. cash flow cash for the fourth divestiture generation in quarter the Historically, Alliance impacted the the quarter forward fourth Healthcare quarter was by the be
Turning guidance. now year to full
lapping led international were across year, Our was restrictions the a most strong. third severe of and performance quarter clearly rebound pandemic less We in markets. very restrictions to the footfall the in the current peak improved and U.S. last year
and expecting vaccinations than in successfully our at a year-on-year a are Additionally, strong The EPS quarter peak although were the the fourth a slower testament completed we little quarter solid was XX comps the for quarter. this quarter, growth capabilities. vaccinations, prior to executional million third year We rate tougher.
administer less are fourth we to quarter our accelerate ramping vaccinations quarter our and growth We the will up compared third digital the and in plans. healthcare as investments we
EPS to guidance. now Turning
are adjusted factors. guidance from around is We potential high EPS our raising The continuing to three XX% full-year growth. swing to mid basis based on single-digit
forecast our now Firstly, XX in quarter third with million full-year around vaccinations assumes compared in quarter. to fourth million vaccinations million the XX X the
growth a On increasing of an around in X%. growth Secondly, we expect to normal foot our visibility X% COVID-XX reposition operational some returns to adjusted improved as adjusted to EPS many has for quarter summary, have growth drivers. we our are an traffic drag raised earnings basis, X%, And X% of impact to should performance business, and and markets guidance more to investments In around continued reflect EPS changes reopen, company around investments and with transformation fourth we resulted annualized quarter approximately in four the finally, to success. strong XX% patterns. are volatility continued and
cover know strategic key our initiatives. me Let
and continue our physical channels. our the make in We and business through transforming stores progress to through healthcare, deliver in we digital pharmacy which our both ways
care One improved a of spend of model. pharmacists’ is the and our on their through time more core be foundation to the services. adherence healthcare for will integrated simplify outcomes free and role more This health up objectives to
the is steps One and to modernize pharmacies. automate our key of
Our and will around X,XXX together XXX Two plays Dallas, and time, locations an workflow brings pharmacy it around pharmacies. iARx are as these recent are support automated centers Walgreens capabilities. role enhanced now operational investment fulfillment important two Phoenix solutions Over pharmacies. micro supporting and in
deployment next be nine And by decided for completed We to end year have fulfillment the the of micro calendar we the centers. also markets expect XXXX.
plans patient our are rollout with VillageMD positive We following continued accelerating also response.
calendar and We further this locations have the calendar by XX sites, this opened XX be This year. end bring a will of year. sites already approximately by XX have identified we opened the number co-located of to the to of end
co-locations. formed an are integrated services the virtual give to in co-locations, available at collaboration addition these This an physical Walgreens In access nine we same to patients will that healthcare additional with locations. VillageMD pharmacy the expanded
our and provide Finally, testing range in are COVID of testing, wider building forward. we on customers our our success to developing diagnostics for going a solutions business
retail. value, turning across evolving U.S. Now to our We're model retail consumer services and convenience.
quarter. our platform around personalization additional is refining and We're offerings XXX in nicely Our was gain prior customer XX progressing Membership engagement sales the building the million momentum. by and XX% boosted to over insights. quarter we simply myWalgreens members mass basis up consumer as personalized points of retail
pandemic Secondly, is to the work options throughout offer we've the experience improve omnichannel undertaken our with and consumers. convenience resonating
quickly drive-thru curbside, completed past orders. mentioned are have shape. we've taking and delivery streams million the last profit in X alternative The now We mile
offerings Our helping better digital uniquely working dataset. based now third-party them our Walgreens with across Advertising with first-party and is Group video, on and customers, is brand providers connect expanding scaled its
credit of debit Additionally, to we early fall, products. in launch the series card plan exciting a and
behind the it product completed SAP will operational point speed efficiencies Finally, a And of availability delivery. capital of working rollout customer we've unlock improve view, of improvements. S/XHANA. the scenes, and This and will from significant
initiatives. international door next Turning
progress an Boots excellent services healthcare with and online in made available. developing offering. During providers healthcare we Hub Boots almost the third-party now Health XXX offers quarter, digital now for our marketplace
follow the innovative which online. with the doctors patients advice DOCTOR, can As in we Boots more physicians connects and to Hub, over from a part ONLINE service, seek future. XX Patients launched market-leading conditions on of new Health recently and
this recently beauty now lifting year. over And the and to discretionary gradually XXX strong side, UK on with XX% gains their the brands share products, On introduced gradual And as particularly spend in increasing we We restrictions. the we've major are to market XX in in quarter, capitalize have retail of categories. customers delivered available online sales life brands returns the marketing campaign stores a new quarter. our in normal, advancing beauty launched designed with on
a COVID the in support is undertaken are million in We programs. continued to quarter, booster one tests vaccination the in play UK's test completed with providers to-date, Boots COVID the NHS. and to leading X partnership over well-positioned testing major of role mostly with
stores, private for Roz a offering China, a hand X,XXX tests have almost have also comments. I'll last we callout We year. And testing several it stores now up growing test same a major and X,XXX several period with quick to in-store at-home in back to compared addition now closing to to the partnerships available, with airlines. finally,